| Name
|
[Tyr0]-C-Peptide, human
|
| Code
|
[57327-90-9]
|
| The alias
|
[Tyr0]-C-Peptide, human
|
| Sequence (single letter abbreviation)
|
YEAEDLQVGQVELGGGPGAGSLQPLALEGSLQ
|
| Sequence (three-letter abbreviation)
|
H-Tyr-Glu-Ala-Glu-Asp-Leu-Gln-Val-Gly-Gln-Val-Glu-Leu-Gly-Gly-Gly-Pro-Gly-Ala-Gly-Ser-Leu-Gln-Pro-Leu-Ala-Leu-Glu-Gly-Ser-Leu-Gln-OH (trifluoroacetate salt)
|
| A basic description
|
The C-peptide of this peptide is important for the biosynthesis of insulin, though for a long time has previously been considered to be biologically inert. Studies now point to C-peptide administration being accompanied by augmented blood flow in skeletal muscle and skin.
|
| solubility
|
|
| The molecular weight
|
3183.5
|
| Chemical formula
|
C138H220N36O50
|
| The purity
|
80%，90%，95%，98%，99%
|
| Weight
|
1mg,5mg,10mg,50mg,100mg,1g
|
| Storage conditions
|
Store at -20°C. Keep tightly closed. Store in a cool dry place.
|
| Annotation
|
|
| Documents
|
|
| Figures
|
|
| Reference
|
V.K. Naithani et al., Hoppe Seylers Z. Physiol. Chem., 356, 1305 (1975)
N. Yanaihara et al., Hoppe Seylers Z. Physiol. Chem., 362, 775 (1981)
H. Sun et al., Appl. Biochem. Biotechnol., 55, 167 (1995)
|
| The C-terminal
|
|
| The N-terminal
|
|
| Chemical bridge
|
|